FIELD: chemistry of peptides, medicine, virology, pharmacy.
SUBSTANCE: invention relates to compounds of PEG-containing polypeptide T1249. Also, invention describes pharmaceutical compositions comprising compounds of PEG-containing polypeptide T1249, methods for their preparing and using in pharmaceutical composition for preparing a medicinal agent used for inhibition of HIV-infection.
EFFECT: valuable medicinal properties of polypeptide, improved preparing method.
15 cl, 8 tbl, 6 dwg, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEGYLATED POLYPEPTIDE T20 | 2003 |
|
RU2296769C2 |
| FUSION POLYPEPTIDES WITH ENHANCED PHARMACOKINETIC PROPERTIES | 2000 |
|
RU2279883C2 |
| DERIVATIVES OF POLYETYLENE GLYCOL ALDEHYDE | 2003 |
|
RU2288212C2 |
| HYBRID POLYPEPTIDES WITH IMPROVED PHARMACOKINETIC PROPERTIES | 1999 |
|
RU2236865C2 |
| PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING GROWTH HORMONE-ASSOCIATED DISEASES IN HUMANS | 2014 |
|
RU2689336C2 |
| PEG-CONTAINING CONJUGATES OF HGF-NK4 | 2002 |
|
RU2293574C2 |
| PHARMACEUTICAL COMPOUNDS FOR OPTIMISED INJECTION OF gp41 HIV DERIVED PEPTIDES AND THEIR THERAPEUTIC APPLICATION | 2003 |
|
RU2357749C2 |
| NEW VERSION OF EXENDIN OR ITS CONJUGATE | 2010 |
|
RU2528734C2 |
| PHARMACEUTICAL COMPOSITION AND A METHOD OF TREATMENT OF GROWTH HORMONE-RELATED DISEASES IN HUMANS | 2019 |
|
RU2802215C2 |
| PEGYLATED COMPOUNDS OF RECOMBINANT HUMAN GROWTH HORMONE | 2009 |
|
RU2530714C9 |
